Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels

American Journal of Medicine

Volumn 125, Issue 1, 2012, Pages 44-49

  Baroletti, Steven ^a   Hurwitz, Shelley ^b   Conti, Nicole A S ^b   Fanikos, John ^b   Piazza, Gregory ^b   Goldhaber, Samuel Z ^b  

^a METROWEST MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antiplatelet factor 4 antibody; Deep vein thrombosis; Enzyme linked immunosorbent assay; Heparin induced thrombocytopenia; Low molecular weight heparin; Pulmonary embolism; Unfractionated heparin; Venous thromboembolism

Indexed keywords

HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; THROMBOCYTE FACTOR 4;

AGED; ANTIBODY BLOOD LEVEL; ARTERY THROMBOSIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK FACTOR; VEIN THROMBOSIS;

AGED; ANTIBODIES; ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET FACTOR 4; THROMBOCYTOPENIA; THROMBOSIS;

EID: 84455208206     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.06.025     Document Type: Article

References (24)

1. G.M. Arepally, T.L. Ortel Clinical practice Heparin-induced thrombocytopenia N Engl J Med 355 2006 809 817
2. J.G. Kelton The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment Chest 127 2005 9S 20S
3. E. Shantsila, G.Y. Lip, B.H. Chong Heparin-induced thrombocytopenia A contemporary clinical approach to diagnosis and management Chest 135 2009 1651 1664
4. T.E. Warkentin New approaches to the diagnosis of heparin-induced thrombocytopenia Chest 127 2005 35S 45S
5. A. Greinacher, P. Eichler, T. Lietz, T.E. Warkentin Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia Blood 106 2005 2921 2922
6. T.E. Warkentin, A. Greinacher, A. Koster, A.M. Lincoff Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 340S 380S
7. R.T. Williams, L.V. Damaraju, M.A. Mascelli Anti-platelet factor 4/heparin antibodies: An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes Circulation 107 2003 2307 2312
8. A. Greinacher, D. Juhl, U. Strobel Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity of the lgG, IgM, and IgA classes J Thromb Haemost 5 2007 1666 1673
9. T. Bakchoul, A. Giptner, A. Najaoui Prospective evaluation of PF4/ heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia J Thromb Haemost 7 2009 1260 1265
10. T.E. Warkentin, J.I. Sheppard, J.C. Moore Quantitative interpretation of optical density measurements using pf4-dependent enzyme-immunoassays J Thromb Haemost 6 2008 1304 1312
11. S. Baroletti, C. Piovella, J. Fanikos Heparin-induced thrombocytopenia: clinical and economic outcomes Thromb Haemost 100 2008 1130 1135
12. C. Pouplard, J. Amiral, J.Y. Borg Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia Am J Clin Pathol 111 1999 700 706
13. T.E. Warkentin, J.A. Sheppard, P. Horsewood Impact of the patient population on the risk for heparin-induced thrombocytopenia Blood 96 2000 1703 1708
14. A. Kuitunen, R. Suojaranta-Ylinen, P. Raivio Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome J Cardiothorac Vasc Anesth 21 2007 18 22
15. G.K. Lo, C.S. Sigouin, T.E. Warkentin What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol 82 2007 1037 1043
16. T.E. Warkentin, M.N. Levine, J. Hirsh Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
17. G.K. Lo, D. Juhl, T.E. Warkentin Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings J Thromb Haemost 4 2006 759 765
18. L. Chilver-Stainer, B. Lammle, L. Alberio Titre of anti-heparin/PF4- antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems Thromb Haemost 91 2004 276 282
19. F. Altuntas, K. Matevosyan, J. Burner Higher optical density of an antigen assay predicts thrombosis in patients with heparin-induced thrombocytopenia Eur J Haematol 80 2008 429 435
20. J.I. Zwicker, L. Uhl, W.-Y. Huang Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia J Thromb Haemost 2 2004 2133 2137
21. L. Rice, W.K. Attisha, A. Drexler, J.L. Francis Delayed-onset heparin-induced thrombocytopenia Ann Intern Med 136 2002 210 215
22. T.E. Warkentin, J.G. Kelton Temporal aspects of heparin-induced thrombocytopenia N Engl J Med 344 2001 1286 1292
23. T.E. Warkentin, J.G. Kelton Delayed-onset heparin-induced thrombocytopenia and thrombosis Ann Intern Med 135 2001 502 506
24. G.B. Oliveira, E.M. Crespo, R.C. Becker Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy Arch Intern Med 168 2008 94 102